Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ABCB5
REST API REST API
Homo sapiens
ABCB5 is differentially expressed in 109 experiments: 39 organism parts: bone marrow, mammary gland, ... (37 more);, 36 disease states: normal, healthy, ... (34 more);, 42 cell types 38 cell lines 12 compound treatments and 43 other conditions.
Synonyms ABCB5beta, ABCB5alpha, EST422562
Orthologs ENSCING00000010768 (Ciona intestinalis)   Abcb5 (Rattus norvegicus)   ABCB5 (Bos taurus)   F6UT57_CIOIN (Ciona intestinalis)   F6U3N6_CIOIN (Ciona intestinalis)   Abcb5 (Mus musculus)   CG10226 (Drosophila melanogaster)   Mdr50 (Drosophila melanogaster)   Mdr49 (Drosophila melanogaster)   Mdr65 (Drosophila melanogaster)   STE6 (Saccharomyces cerevisiae)   ENSXETG00000033201 (Xenopus laevis)   LOC100492825 (Xenopus laevis)   LOC100485969 (Xenopus laevis)   ABCB5 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term plasma membrane, transport, nucleoside-triphosphatase activity, Golgi membrane, ATPase activity, regulation of membrane potential, ATP binding, ATPase activity, coupled to transmembrane movement of substances, integral to plasma membrane, nucleotide binding, apical plasma membrane, integral to membrane, transmembrane transport, efflux transmembrane transporter activity, intercellular canaliculus
InterPro Term ATPase_AAA+_core, ABC_transporter-like, ABC_transptr_TM_dom, ABC_transporter_type1, ABC_ATPase_put
UniProt Accession B5MD19, Q2M3G0, A4D132, F8QQP8
Search EB-eye ENSG00000004846
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-18105, E-MTAB-69, E-TABM-130, E-MTAB-47, ... (9 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-5823, E-MEXP-2034, E-GEOD-19466, E-GEOD-20089, E-GEOD-19639, ... (12 experiments)

Factor Value U/D Experiments
YCC11
1
E-GEOD-15460
U251
1
E-GEOD-20089
NA18858
1
E-GEOD-19480
BT-474
1
1
E-GEOD-5823
LNCaP
1
E-GEOD-14990
MCF-10A
1
E-GEOD-14990
32 more value(s).


Cell type

studied in E-GEOD-18811, E-AFMX-5, E-GEOD-21668, E-TABM-130, E-GEOD-1460, ... (19 experiments)

Factor Value U/D Experiments
CD34 positive
1
E-GEOD-12662
memory B cell
1
E-TABM-702
undifferentiated cell
1
E-GEOD-21668
spermatocyte
1
E-TABM-130
CD19+ B cells (neg. sel.)
1
E-AFMX-5
BDCA1+ dendritic cell
1
1
E-TABM-34
36 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-19743, E-GEOD-6872, E-GEOD-15960, E-MEXP-1121, ... (24 experiments)

Factor Value U/D Experiments
normal
3
4
E-TABM-702, E-GEOD-6338, E-GEOD-2685, E-MEXP-2069, E-GEOD-12662, ... (7 experiments)
breast carcinoma
1
E-GEOD-7307
CLL (Chronic Lymphocytic Leukemia)
1
1
E-GEOD-16455
inhalation injury
1
E-GEOD-19743
LF (follicular lymphoma)
1
1
E-GEOD-16455
oligodendroglioma
1
E-GEOD-4290
30 more value(s).


Compound treatment

studied in E-GEOD-3284, E-GEOD-15205, E-GEOD-5741, E-GEOD-4984, E-GEOD-7307, ... (6 experiments)

Factor Value U/D Experiments
estradiol
1
E-GEOD-20081
control - vehicle
1
1
E-GEOD-4984
galectin-1
1
E-GEOD-4984
unknown
1
E-GEOD-7307
control
11
1
E-GEOD-3284
LDL
1
1
E-GEOD-5741
6 more value(s).


Age at diagnosis

studied in E-GEOD-21653

Factor Value U/D Experiments
28
2
1
E-GEOD-21653
31
1
1
E-GEOD-21653


Agent
studied in E-GEOD-19519

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Clinical history
studied in E-GEOD-22097, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, ... (8 experiments)

Clinical info
studied in E-GEOD-19743, E-GEOD-19348, E-GEOD-20499, E-GEOD-21589, E-GEOD-16363, ... (8 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-89, E-GEOD-19743, E-GEOD-22544, E-GEOD-22148, E-GEOD-21138 ... (5 experiments)

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

Ethnicity
studied in E-GEOD-21589

family id
studied in E-GEOD-19519

Genotype
studied in E-GEOD-17476, E-MEXP-421, E-TABM-868, E-GEOD-3790, E-GEOD-17347, ... (6 experiments)

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-GEOD-13073, E-GEOD-20540, E-MEXP-2146

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-666, E-GEOD-19519, E-GEOD-6919, ... (15 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-17400

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-18791

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Treatment
studied in E-GEOD-16837, E-GEOD-19246

Processing time: 0.515 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM